Inovio Pharmaceuticals Inc. Stock Advances 16.9%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. surged 16.9% to $0.90 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.8% to 26,803.03 and the Dow Jones Industrial Average rising 0.1% to 53,839.99.

This was the stock's fourth consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 69.8% short of its 52-week high of $2.98, which the company reached on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 0.5% to $262.08, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 1.86% to $26.80.

Trading volume totaled 12.6 million, compared to the 50-day average of 2.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 13, 2026 16:33 ET (20:33 GMT)